Source:http://linkedlifedata.com/resource/pubmed/id/15919667
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
2005-7-19
|
pubmed:abstractText |
Clostridium perfringens phospholipase C (Cp-PLC), also called alpha-toxin, is the major virulence factor in the pathogenesis of gas gangrene. Previously, a cellular UDP-Glc deficiency was related with a hypersensitivity to the cytotoxic effect of Cp-PLC. Because UDP-Glc is required in the synthesis of proteoglycans, N-linked glycoproteins, and glycosphingolipids, the role of these gly-coconjugates in the cellular sensitivity to Cp-PLC was studied. The cellular sensitivity to Cp-PLC was significantly enhanced by glycosphingolipid synthesis inhibitors, and a mutant cell line deficient in gangliosides was found to be hypersensitive to Cp-PLC. Gangliosides protected hypersensitive cells from the cytotoxic effect of Cp-PLC and prevented its membrane-disrupting effect on artificial membranes. Removal of sialic acids by C. perfringens sialidase increases the sensitivity of cultured cells to Cp-PLC and intramuscular co-injection of C. perfringens sialidase, and Cp-PLC in mice potentiates the myotoxic effect of the latter. This work demonstrated that a reduction in gangliosides renders cells more susceptible to the membrane damage caused by Cp-PLC and revealed a previously unrecognized synergism between Cp-PLC and C. perfringens sialidase, providing new insights toward understanding the pathogenesis of clostridial myonecrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Gangliosides,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/Neuraminidase,
http://linkedlifedata.com/resource/pubmed/chemical/Sialic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Type C Phospholipases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
280
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
26680-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15919667-Animals,
pubmed-meshheading:15919667-Cell Line,
pubmed-meshheading:15919667-Cell Membrane,
pubmed-meshheading:15919667-Clostridium perfringens,
pubmed-meshheading:15919667-Drug Synergism,
pubmed-meshheading:15919667-Gangliosides,
pubmed-meshheading:15919667-Humans,
pubmed-meshheading:15919667-Hypersensitivity,
pubmed-meshheading:15919667-Liposomes,
pubmed-meshheading:15919667-Mice,
pubmed-meshheading:15919667-Neuraminidase,
pubmed-meshheading:15919667-Sialic Acids,
pubmed-meshheading:15919667-Type C Phospholipases
|
pubmed:year |
2005
|
pubmed:articleTitle |
A cellular deficiency of gangliosides causes hypersensitivity to Clostridium perfringens phospholipase C.
|
pubmed:affiliation |
Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm S-17177, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|